In this issue:
Hydroxychloroquine in hospitalised patients with COVID-19
Hydroxychloroquine as postexposure prophylaxis for COVID-19
Convalescent plasma therapy for severe and life-threatening COVID-19
Recombinant adenovirus type-5 vectored COVID-19 vaccine
Baloxavir marboxil for uncomplicated influenza
CRP-guided antibiotic treatment duration
Incidence, microbiology and outcomes for infective endocarditis
Treatment duration of antibiotics for acute uncomplicated cystitis
Pathogens and antibiotic resistance genes in a tertiary hospital
Rifabutin hyperactivity against Acinetobacter baumannii
Please login below to download this issue (PDF)